New insulin boosts artificial pancreas performance in type 1 diabetes trial
NCT ID NCT05508061
First seen Feb 19, 2026 · Last updated May 23, 2026 · Updated 11 times
Summary
This study tested a faster-acting insulin (Lyumjev) in an artificial pancreas system for people with type 1 diabetes. Twelve adults who already used the artificial pancreas took part. The goal was to see if the new insulin kept blood sugar in a healthy range better than the standard insulin, while also checking for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Gelderse Vallei
Ede, Gelderland, 6716 RP, Netherlands
-
Rijnstate Hospital
Arnhem, Gelderland, 6815 AD, Netherlands
-
Slingeland Hospital
Doetinchem, Gelderland, 7009 BL, Netherlands
Conditions
Explore the condition pages connected to this study.